
|Articles|October 1, 2005
Welcome to Ophthalmology Times Europe
I often feel that the European ophthalmology industry is becoming the victim of its own success. With the half-life value of ophthalmic knowledge on the continent now set at less than five years, compared with 30 years in 1960, innovation in Europe is not showing any signs of slowing down. Ophthalmologists in Europe are continuously required to update and broaden their specialist knowledge with the advent of new techniques, treatments, instruments and devices. With meetings every few weeks, around the globe, on all branches of ophthalmic science and clinical practice, how is it possible to keep up?
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
2026 Nobel Prize in Physiology or Medicine awarded for optogenetics discovery
2
Oku Digital Health launches from Topcon to link eye care, primary care
3
EURETINA 2026: Eyestem interim Phase 2 results for clinical study of Eyecyte-RPE for GA secondary to dry AMD
4
EURETINA 2026: Optogenetic therapy MCO-010 aims to restore vision in advanced macular disease
5




